DK0776214T3 - Antibakterialt præparat indeholdende multimert alfa-lactalbumin - Google Patents

Antibakterialt præparat indeholdende multimert alfa-lactalbumin

Info

Publication number
DK0776214T3
DK0776214T3 DK94928519T DK94928519T DK0776214T3 DK 0776214 T3 DK0776214 T3 DK 0776214T3 DK 94928519 T DK94928519 T DK 94928519T DK 94928519 T DK94928519 T DK 94928519T DK 0776214 T3 DK0776214 T3 DK 0776214T3
Authority
DK
Denmark
Prior art keywords
lactalbumin
alpha
preparation containing
antibacterial preparation
containing multimeric
Prior art date
Application number
DK94928519T
Other languages
Danish (da)
English (en)
Inventor
Catharina Svanborg
Hemant Sabharwal
Original Assignee
Catharina Svanborg
Hemant Sabharwal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catharina Svanborg, Hemant Sabharwal filed Critical Catharina Svanborg
Application granted granted Critical
Publication of DK0776214T3 publication Critical patent/DK0776214T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/24—Extraction; Separation; Purification by electrochemical means
    • C07K1/26—Electrophoresis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/285—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Electrochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Mycology (AREA)
DK94928519T 1994-08-16 1994-08-16 Antibakterialt præparat indeholdende multimert alfa-lactalbumin DK0776214T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE1994/000742 WO1996004929A1 (en) 1994-08-16 1994-08-16 Antibacterial composition containing multimeric alpha-lactalbumin

Publications (1)

Publication Number Publication Date
DK0776214T3 true DK0776214T3 (da) 1999-11-29

Family

ID=20393168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94928519T DK0776214T3 (da) 1994-08-16 1994-08-16 Antibakterialt præparat indeholdende multimert alfa-lactalbumin

Country Status (11)

Country Link
US (2) US6599874B1 (de)
EP (1) EP0776214B1 (de)
JP (1) JP3694319B2 (de)
AT (1) ATE182470T1 (de)
AU (1) AU7792294A (de)
CA (1) CA2197659C (de)
DE (1) DE69419782T2 (de)
DK (1) DK0776214T3 (de)
ES (1) ES2136206T3 (de)
GR (1) GR3031078T3 (de)
WO (1) WO1996004929A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
GB9724725D0 (en) * 1997-11-21 1998-01-21 Svanborg Catharina Protein production process
ES2286860T3 (es) * 1997-11-21 2007-12-01 Nya Hamlet Pharma Ab Proceso de produccion de lactoalbumina.
GB9725126D0 (en) 1997-11-27 1998-01-28 Svanborg Catharina Therapeutic agents
DE60040856D1 (de) * 1999-07-28 2009-01-02 Morinaga Milk Industry Co Ltd Lactalbumin zur kurativen Behandlung von Magengeschwüren
EP1427436B1 (de) * 2001-08-23 2008-07-02 Westgate Biological Limited Verwendung von milchserum-apoproteinen bei der prophylaxe oder behandlung von mikrobiellen oder virusinfektionen
GB0210464D0 (en) 2002-05-08 2002-06-12 Svanborg Catharina Therapeutic treatment
CN102590413B (zh) * 2012-01-18 2013-12-25 浙江省疾病预防控制中心 一种牛α-乳白蛋白的定量检测方法
WO2014023976A1 (en) 2012-08-09 2014-02-13 Hamlet Pharma Ab Prophylactic and nutraceutical therapy
WO2024075003A1 (en) 2022-10-03 2024-04-11 Linnane Pharma Ab A complex comprising a alpha-lactalbumin and a fatty acid or lipid for use in the treatment or prevention of cancer
GB202303177D0 (en) 2023-03-03 2023-04-19 Linnane Pharma Ab Method of predicting response to treatment
WO2025186107A1 (en) 2024-03-04 2025-09-12 Linnane Pharma Ab Therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
EP0058665B1 (de) 1980-05-09 1986-02-26 LEFFLER, Hakon Carbohydrat-derivate zum hemmen eines bakteriellen anhaftens
CA1333471C (en) * 1988-04-29 1994-12-13 Gustavo Bounous Whey protein concentrate as food supplement
US5968901A (en) * 1989-10-30 1999-10-19 Andersson; Bengt Antibacterial composition
US5795611A (en) 1989-12-20 1998-08-18 Slattery; Charles W. Human infant formulas containing recombinant human alpha-lactalbumin and beta-casein
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法

Also Published As

Publication number Publication date
EP0776214A1 (de) 1997-06-04
EP0776214B1 (de) 1999-07-28
ATE182470T1 (de) 1999-08-15
US6599874B1 (en) 2003-07-29
US7144855B2 (en) 2006-12-05
US20040106541A1 (en) 2004-06-03
DE69419782D1 (de) 1999-09-02
DE69419782T2 (de) 1999-12-23
JPH10504547A (ja) 1998-05-06
ES2136206T3 (es) 1999-11-16
CA2197659C (en) 2009-11-10
GR3031078T3 (en) 1999-12-31
CA2197659A1 (en) 1996-02-22
WO1996004929A1 (en) 1996-02-22
AU7792294A (en) 1996-03-07
JP3694319B2 (ja) 2005-09-14

Similar Documents

Publication Publication Date Title
CA2189658A1 (en) Controlled-Release Dosage Forms of Azithromycin
DE3462255D1 (en) Quinolone carboxylic acids, process for their preparation and antibacterial compositions containing them
DK0759774T3 (da) Fremgangsmåde til behandling af gram-negativ bakteriel infektion ved indgivelse af baktericidt/permeabilitet-forøgende (BPI) proteinprodukt og antibiotikum
ATE182470T1 (de) Multimeres alpha-lactalbumin enthaltende antibakterielle zusammensetzung
DE59710183D1 (de) Topische mittel zur prophylaxe oder behandlung bakterieller hautinfektionen
GR3029477T3 (en) Vaccine against gram-negative bacterial infections
NZ332720A (en) Therapeutic uses of bactericidal/permeability increasing (BPI) protein to treat human meningococcemia
CA2396561A1 (en) Substituted oxazolidinones and their use in the field of blood coagulation
IL156942A0 (en) Compounds, pharmaceutical compositions and methods for treatment of bacteremia and/or septicemia
AU2967595A (en) Anti-protozoan methods and materials
ATE258057T1 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
WO2000058475A3 (en) Streptococcus pneumoniae antigens
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
KR880701734A (ko) 글리코 펩티드 항생물질
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
SE8903625L (sv) Antibacterial composition
DE69739775D1 (de) Verabreichung von Produkten des 5-lipoxygenase Synthesewegs zur Behandlung von mikrobiellen Infektionen
Ginsburg Streptococcus.
GB9811347D0 (en) Improvements in or relating diagnosis and treatment of bacterial infections
WO2001096381A3 (en) IMMUNIZATION OF DAIRY CATTLE WITH GapC PROTEIN AGAINST STREPTOCOCCUS INFECTION
WO2002000839A3 (en) Statement as to federally sponsored research
WO1998021231A3 (en) Streptococcus uberis lactoferrin-binding protein
Scatizzi et al. Prevention of Staphylococcus aureus peritonitis in continuous ambulatory peritoneal dialysis
Anzueto et al. Safety and efficacy of clarithromycin vs cefuroxime axetil in the treatment of acute bacterial exacerbation of chronic bronchitis.